News Booth’s Student Entrepreneurship Awards Honor Budding Leaders in Entrepreneurship, Venture Capital and Private Equity Chicago Booth last month recognized six outstanding MBA students who demonstrated leadership in entrepreneurship, venture capital or private equity during their time at school. The annual Student Entrepreneurship Awards have...
Page Venture Gallery Venture Gallery View startups founded from across the University of Chicago ecosystem in a range of industries. Welcome to the Venture Gallery! The Polsky Center provides “first look” and early...
News Monsters of the Midway UChicago licensee NephRx is moving swiftly to bring to market therapeutics for patients with kidney transplants and mucositis. Nephrology professor Gary Toback, MD, PhD (left) developed the therapies that have...
News UChicago Professors and Grad Students Among 2021’s Highly Cited Researchers More than 30 professors and graduate students at the University of Chicago were among Clarivate’s annual list of Highly Cited Researchers. The list, which included University of Chicago President, Paul...
Technology Nanomaterial Based Intracellular Drug Delivery Of Therapeutic Peptides Intracellular delivery involves introduction of small biomolecules, nucleic acids, proteins, synthetic nanomaterials and drugs into the cell. There is a lot of focus on targeted intracellular delivery for improved therapy…
Technology FOXP3 Stapled Peptides to Deactivate Regulatory T Cells Regulatory T cells (Tregs) modulate immune function by preventing autoreactive T cell responses, including those that would normally target cancer cells. Treg activity can significantly limit the efficacy of immunotherapies…
Technology Hydrocarbon-Stapled Peptides To Inhibit SARS-CoV-2 Viral Infection The SARS-CoV-2 virus spreads by binding its spike protein to the human angiotensin-converting enzyme 2 (hACE2) protein expressed at the cell surface of lungs, arteries, heart, kidney, and intestines. The…
Technology Expanding CAR T Cells Using Venetoclax For Enhanced Cytolytic Activity Against Tumors Expanding CAR T cells with venetoclax enhances their ability to target and kill CD19+ tumor cells, increases their effectiveness, and reduces exhaustion, potentially leading to better treatment outcomes for diffuse…
Page Polsky Council The Polsky Council comprises many of the country’s leading entrepreneurs, venture capitalists, and private equity investors, who provide ongoing guidance and support to the Polsky Center. Eric Belcher, MBA ’95...
News Polsky Center Announces 2018 Summer Accelerator Cohort The Polsky Center for Entrepreneurship and Innovation is pleased to announce the latest cohort of the Polsky Accelerator, a 10-week intensive summer program designed for both for-profit and not-for-profit startups to...
News Polsky Accelerator Program Concludes with Demo Day For the past 10 weeks, 14 companies have participated in the 2018 Polsky Accelerator program. The annual program is designed for both for-profit and not-for-profit startups to develop their ventures....
News Polsky Center Announces Autumn 2018 I-Corps Program Cohort The Polsky Center for Entrepreneurship and Innovation is pleased to announce the latest cohort of the Polsky I-Corps program, a 7-week highly-experiential program designed to empower UChicago scientists, researchers, and...
